Jhm. Prehn et Rj. Miller, OPPOSITE EFFECTS OF TGF-BETA-1 ON RAPIDLY-TRIGGERED AND SLOWLY-TRIGGERED EXCITOTOXIC INJURY, Neuropharmacology, 35(3), 1996, pp. 249-256
Transforming growth factor-beta (TGF-beta) has been shown to protect c
entral neurons against diverse metabolic and excitotoxic challenges. W
e induced different types of excitotoxic injury on cultured rat hippoc
ampal neurons and investigated TGF-beta 1 for its protective activity.
TGF-beta 1 (0.3-10 ng/ml) effectively blocked excitotoxic injury of c
ultured rat hippocampal neurons induced by short-term exposure to the
selective agonist N-methyl-D-aspartate (NMDA; 100 mu M, 20 min). Excit
otoxic injury caused by long-term exposure to the non-NMDA agonists ka
inate (50 mu M, 24 hr) or lpha-amino-3-hydroxy-5-methyl-4-isoxazolepro
pionic acid (AMPA; 10 mu M, 24 hr) caused a similar reduction in neuro
nal viability. However, treatments with TGF-beta 1 (0.1-10 ng/ml) actu
ally potentiated this slowly-triggered excitotoxic injury. Cultures of
rat cerebellar neurons enriched for Purkinje cells have been shown to
express AMPA/kainate receptors with significant permeability to Ca2and to be uniquely sensitive to non-NMDA receptor-mediated neurotoxici
ty. In this culture system, short-term exposure to kainate (100 mu M;
30 min) in Na+-free extracellular solution caused a pronounced decreas
e in neuronal viability, and this toxicity was also significantly redu
ced in cultures treated with TGF-beta 1 (10 ng/ml). These results sugg
est that TGF-beta 1 has the capacity to protect neurons against rapidl
y-triggered, Ca2+-mediated excitotoxic injury, but significantly poten
tiates slowly-triggered types of excitotoxic injury. This complex acti
on of TGF-beta 1 could have important implications for the use of TGF-
beta s and related growth factors in the treatment of neurodegenerativ
e diseases. Copyright (C) 1996 Elsevier Science Ltd.